Diagnosis of some genital-tract infections: part 1. An historical perspective

2017 ◽  
Vol 28 (11) ◽  
pp. 1143-1149 ◽  
Author(s):  
David Taylor-Robinson ◽  
Anna Pallecaros ◽  
Patrick Horner

Making a prompt and accurate diagnosis of genital tract infections is the key to instituting appropriate treatment and the linchpin of sexually transmitted infection control. We present a brief history, not covering syphilis, of diagnostic events for each of six bacteria and one protozoan from the time of discovery up to the molecular revolution. The latter is touched upon but its impact will form the substance of a further presentation. Here, hindsight is helpful in understanding the way in which progress was made over 135 years, often when microbiology, not even seen as a distinct discipline, had a difficult time in providing what was required in terms of dependable diagnostic techniques. Gram-staining, growth on artificial media, growth in cultured cells, enzyme immunoassays, metabolic and immunofluorescence tests have all had their place and some still do despite the avalanche of the molecular era. Serology to determine the existence of organism-specific antibodies has been important in managing syphilis, but has only sometimes been helpful in supporting a diagnosis for other infections and has rarely been the primary deciding factor.

2014 ◽  
Vol 2014 ◽  
pp. 1-8 ◽  
Author(s):  
Achchhe L. Patel ◽  
Prashant K. Mishra ◽  
Divya Sachdev ◽  
Uma Chaudhary ◽  
Dorothy L. Patton ◽  
...  

Chlamydia trachomatis(CT) is an important cause of sexually transmitted genital tract infections (STIs) and trachoma. Despite major research into chlamydial pathogenesis and host immune responses, immunoprotection has been hampered by the incomplete understanding of protective immunity in the genital tract. Characterized vaccine candidates have shown variable efficacy ranging from no protection to partial protectionin vivo. It is therefore a research priority to identify novel chlamydial antigens that may elicit protective immune responses against CT infection. In the present study we assessed the seroprevalence of antibodies against protein kinase1 (Pkn1), DNA ligaseA (LigA), and major outer membrane protein A (OmpA) following natural CT infection in humans and in experimentally induced CT infection inMacaca nemestrina. Antigenic stretches of Pkn1, LigA, and OmpA were identified using bioinformatic tools.Pkn1,LigA, andOmpAgenes were cloned in bacterial expression vector and purified by affinity chromatography. Our results demonstrate significantly high seroprevalence of antibodies against purified Pkn1 and OmpA in sera obtained from the macaque animal model and human patients infected with CT. In contrast no significant seroreactivity was observed for LigA. The seroprevalence of antibodies against Pkn1 suggest that nonsurface chlamydial proteins could also be important for developing vaccines forC. trachomatis.


1994 ◽  
Vol 5 (3) ◽  
pp. 212-213 ◽  
Author(s):  
N Smith ◽  
M R Nelson ◽  
J Hammond ◽  
S Purkayastha ◽  
S E Barton

Over a four-month study period, 87 patients requesting termination of pregnancy at a gynaecology clinic were offered screening for sexually transmitted diseases, of whom 63 accepted. A total of 41 infections were found in 34 women, the commonest being vaginal candidiasis and bacterial vaginosis. Chlamydia was found in six patients. Although HIV antibody testing was offered to every patient, all declined this test.


2020 ◽  
pp. 095646241989983
Author(s):  
A Hegazi ◽  
N Ramskill ◽  
M Norbrook ◽  
T Morgan ◽  
E Dwyer ◽  
...  

There are minimal UK data on the prevalence of genital tract infections in HIV‐infected pregnant women. British HIV Association guidelines suggest sexually transmitted infection (STI) screening as early as possible in pregnancy with consideration given to repeat at 28 weeks’ gestation. A retrospective case notes review of HIV-infected pregnant women at four South London HIV Centres (1 January 2004–1 January 2014) was carried out. Five hundred and ninety-eight pregnancies in 384 patients were identified. Median age 32 years (interquartile range [IQR] 27–36) and 96% (n = 346) were heterosexually infected. HIV was diagnosed antenatally in 21% of pregnancies (n = 107). Seventy-seven per cent of women (n = 384) were of Black African ethnicity and 75% were born in sub-Saharan Africa with 14% UK-born. The majority of pregnancies (279/507) were reported to be unplanned with 42 women proceeding to termination of pregnancy. A regular male partner was reported in 95% of pregnancies (n = 539) with median relationship duration (n = 347) of four years (IQR 1.5–7.0); 11/324 (3.4%) women reported additional sexual partners during the pregnancy. 76.6% (n = 427) of women had an initial STI screen which was done in the first trimester in 52.1%; 32.1% of women had a repeat STI screen in pregnancy, 96% of which was done in the third trimester. Overall, 61 (14.3%) women were diagnosed with at least one STI during their pregnancy. Vaginal candidiasis and bacterial vaginosis were diagnosed in 27.6% (n = 100) and 21.7% (n = 73) of pregnancies, respectively. STI prevalence was low and obstetric outcomes favourable in this cohort of women. Further information about STI prevalence in this population may impact future screening guidelines.


There are more than 340 million new cases of sexually transmitted infections (STIs) occurred annually throughout the world, the highest incidence is in people of developing countries. Pelvic inflammation, sterility, ectopic pregnancy, morbidity and mortality of newborns, and genital carcinoma have been assumed to be related to STIs. Sexually transmitted diseases have various clinical symptoms while 70% gonococcal or non-gonococcal urethritis in males and genital tract infections in females are asymptomatic, both symptomatic and asymptomatic infections may cause severe complications, previous studies revealed that wide range of pathogens recognized as a causative agents of urethritis in males and genital tract infections in females, such as Trichomonas vaginalis and herpes simplex virus. More epidemiological studies are needed to evaluate the significant role of organisms other than the recognized genital pathogens in vaginal syndromes. In summary we conclude that sexually transmitted diseases may increase reproductive morbidity rate causing difficulties in conception especially the infection with T. vaginalis and herpes simplex viruses, so concentrating on different methods in diagnosis is required. In addition, the cost and time of the test should be taken in consideration.


Sign in / Sign up

Export Citation Format

Share Document